OHSU in the news

Few cases of superbug Candida auris reported in Oregon

KOIN-TV March 27, 2023
The United States is seeing an increase in reports of candida auris, an often drug-resistant fungal pathogen. OHSU has a strong protocol of infection prevention and control to minimize the risk of spreading pathogens in the hospital, including C. auris.

Long COVID in Clark County: It’s what we don’t know

The Columbian March 26, 2023
Jordan Anderson, D.O., and Jennifer Arnold, B.S.N., RN, discuss long COVID. Anderson says many patients with the chronic condition are also dealing with mental health challenges: “Oftentimes, the situations that people are in with long COVID are very difficult and challenging, which can contribute to depression. The most important thing that I’ve been able to do for the patients that I’ve seen is to listen and validate them.”

The A.D.H.D. medication shortage reflects bad drug policy

The New York Times March 25, 2023
The New York Times interviews Ximena Levander, M.D., about a proposed DEA rule requiring in-person visits after 30 days for people prescribed medication-assisted therapy for substance use disorder through telehealth, including in rural parts of Oregon, several hours away from the nearest clinic. She says, “Where are these people supposed to go? There aren’t primary care or addiction doctors that are available to see people within the first 30 days.”

SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial

Read Magazine March 23, 2023
In a BusinessWire press release announcing results from a phase 1 clinical trial from SQZ Therapeutics, Richard Maziarz, M.D., says: “Although early in this trial, we have observed good tolerability among the patients, the confirmed complete response observed in this patient demonstrates the potential of the investigational therapy’s intended immunotherapy mechanism.”

TUM Researchers Profiling Dose-Dependent Response of Protein PTMs to Cancer Drugs

GenomeWeb March 23, 2023
Gordon Mills, M.D., Ph.D., provides an outside perspective on a new proteomic workflow for measuring the response of protein post-translational modifications to different drugs. Mills says: "This really adds to RNA data and other proteomic data — which is much more sparse than this — to really understand how drugs work, what their targets are, and how cells adapt to the stress of drugs. I think it’s a major new resource that will be used extensively.”

U.S. autism prevalence continues to rise as race and sex gaps shrink, new stats show

Spectrum News March 23, 2023
In an article from Spectrum News, Katharine Zuckerman, M.D., shares insight on the global rise in autism diagnoses: “The prevalence increases we’re seeing in the U.S. are mirrored in other countries to some extent as well. This is a good sign that the pretty significant efforts that pediatricians and public health people and communities are doing towards improving awareness, reducing stigma, improving screening and referring at-risk kids to services are working.”
See more stories